Acadia Pharmaceuticals ACAD Total Cost of Revenue
Total Cost of Revenue at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Acadia Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:CostOfGoodsAndServicesSold.
The official record: Acadia Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Acadia Pharmaceuticals's total cost of revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Acadia Pharmaceuticals's total cost of revenue?
- Acadia Pharmaceuticals (ACAD) reported total cost of revenue of $24.79M in Q1 2026.
- How has Acadia Pharmaceuticals's total cost of revenue changed year-over-year?
- Acadia Pharmaceuticals's total cost of revenue increased by 21.6% year-over-year, from $20.39M to $24.79M.
- What is the long-term trend for Acadia Pharmaceuticals's total cost of revenue?
- Over 4 years (2021 to 2025), Acadia Pharmaceuticals's total cost of revenue has grown at a 46.8% compound annual growth rate (CAGR), from $19.14M to $89M.
- What does total cost of revenue mean?
- The aggregate of all direct costs attributable to producing goods and delivering services that generated the company's revenue, including materials, labor, and overhead.